Latka logo

Founded

2023

Lifesciencemarket.com revenue, CEO Michael Meseke, team size, customer count, churn, and more in 2026.

Lifesciencemarket.com Revenue

We do not have information about Lifesciencemarket.com's revenue yet.

Lifesciencemarket.com Valuation, Funding Rounds

Explore the complete funding history and valuation milestones for this company. Below you will find information about each funding round and key financial metrics that shaped the company's growth trajectory.

Lifesciencemarket.com Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$120232023 cumulative: $0 • 2023 Founded: $02023 Founded: $0 valuationSource: GetLatka.com
YearRoundAmountValuation% Sold

Lifesciencemarket.com Employees & Team Size

We do not have information about Lifesciencemarket.com's team yet.

Founder / CEO

Michael Meseke

Michael Meseke is listed as Founder / CEO at Lifesciencemarket.com.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Lifesciencemarket.com yet.

Frequently Asked Questions about Lifesciencemarket.com

What is Lifesciencemarket.com's revenue?

GetLatka has not confirmed a public revenue figure for Lifesciencemarket.com.

Who is the CEO of Lifesciencemarket.com?

The CEO of Lifesciencemarket.com is Michael Meseke.

How much funding does Lifesciencemarket.com have?

Lifesciencemarket.com raised -.

How many employees does Lifesciencemarket.com have?

Lifesciencemarket.com has - employees.

Where is Lifesciencemarket.com headquarters?

Lifesciencemarket.com is headquartered in Bovenden, Niedersachsen, Germany.

Source Attribution

Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.

Lifesciencemarket.com Revenue, Valuation & Funding (2026)